{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:22:02Z","timestamp":1790835722830,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1038\/cdd.2016.33","type":"journal-article","created":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T14:32:48Z","timestamp":1459521168000},"page":"1483-1492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Restraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancer"],"prefix":"10.1038","volume":"23","author":[{"given":"M","family":"Hornsveld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tenhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"van de Ven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M M","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M H","family":"van Triest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"van Amersfoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D E A","family":"Kloet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T B","family":"Dansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B M","family":"Burgering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P W B","family":"Derksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,1]]},"reference":[{"key":"BFcdd201633_CR1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0955-0674(00)00251-9","volume":"13","author":"SM Frisch","year":"2001","unstructured":"Frisch SM, Screaton RA . Anoikis mechanisms. Curr Opin Cell Biol 2001; 13: 555\u2013562.","journal-title":"Curr Opin Cell Biol"},{"key":"BFcdd201633_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1083\/jcb.139.3.575","volume":"139","author":"MA Schwartz","year":"1997","unstructured":"Schwartz MA . Integrins, oncogenes, and anchorage independence. J Cell Biol 1997; 139: 575\u2013578.","journal-title":"J Cell Biol"},{"key":"BFcdd201633_CR3","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1242\/dev.122.12.4013","volume":"122","author":"RC Humphreys","year":"1996","unstructured":"Humphreys RC, Krajewska M, Krnacik S, Jaeger R, Weiher H, Krajewski S et al. Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. Development 1996; 122: 4013\u20134022.","journal-title":"Development"},{"key":"BFcdd201633_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0092-8674(02)01001-2","volume":"111","author":"J Debnath","year":"2002","unstructured":"Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, Brugge JS . The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 2002; 111: 29\u201340.","journal-title":"Cell"},{"key":"BFcdd201633_CR5","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1073\/pnas.0700115104","volume":"104","author":"T Schmelzle","year":"2007","unstructured":"Schmelzle T, Mailleux AA, Overholtzer M, Carroll JS, Solimini NL, Lightcap ES et al. Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis. Proc Natl Acad Sci USA. 2007; 104: 3787\u20133792.","journal-title":"Proc Natl Acad Sci USA."},{"key":"BFcdd201633_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.devcel.2006.12.003","volume":"12","author":"AA Mailleux","year":"2007","unstructured":"Mailleux AA, Overholtzer M, Schmelzle T, Bouillet P, Strasser A, Brugge JS . BIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanisms. Dev Cell 2007; 12: 221\u2013234.","journal-title":"Dev Cell"},{"key":"BFcdd201633_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.bbamcr.2010.12.019","volume":"1813","author":"D Westphal","year":"2011","unstructured":"Westphal D, Dewson G, Czabotar PE, Kluck RM . Molecular biology of Bax and Bak activation and action. Biochim Biophys Acta 2011; 1813: 521\u2013531.","journal-title":"Biochim Biophys Acta"},{"key":"BFcdd201633_CR8","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1038\/emboj.2011.307","volume":"30","author":"A Strasser","year":"2011","unstructured":"Strasser A, Cory S, Adams JM . Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J 2011; 30: 3667\u20133683.","journal-title":"EMBO J"},{"key":"BFcdd201633_CR9","doi-asserted-by":"publisher","first-page":"26533","DOI":"10.1074\/jbc.M111.265322","volume":"286","author":"M Hausmann","year":"2011","unstructured":"Hausmann M, Leucht K, Ploner C, Kiessling S, Villunger A, Becker H et al. BCL-2 modifying factor (BMF) is a central regulator of anoikis in human intestinal epithelial cells. J Biol Chem 2011; 286: 26533\u201326540.","journal-title":"J Biol Chem"},{"key":"BFcdd201633_CR10","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1126\/science.1062257","volume":"293","author":"H Puthalakath","year":"2001","unstructured":"Puthalakath H, Villunger A, O'Reilly LA, Beaumont JG, Coultas L, Cheney RE et al. Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science 2001; 293: 1829\u20131832.","journal-title":"Science"},{"key":"BFcdd201633_CR11","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.bcp.2008.07.023","volume":"76","author":"P Chiarugi","year":"2008","unstructured":"Chiarugi P, Giannoni E . Anoikis: a necessary death program for anchorage-dependent cells. Biochem Pharmacol 2008; 76: 1352\u20131364.","journal-title":"Biochem Pharmacol"},{"key":"BFcdd201633_CR12","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ncb0901-785","volume":"3","author":"SK Muthuswamy","year":"2001","unstructured":"Muthuswamy SK, Li D, Lelievre S, Bissell MJ, Brugge JS . ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat Cell Biol 2001; 3: 785\u2013792.","journal-title":"Nat Cell Biol"},{"key":"BFcdd201633_CR13","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1158\/0008-5472.CAN-07-3177","volume":"68","author":"CG Danes","year":"2008","unstructured":"Danes CG, Wyszomierski SL, Lu J, Neal CL, Yang W, Yu D . 14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling. Cancer Res 2008; 68: 1760\u20131767.","journal-title":"Cancer Res"},{"key":"BFcdd201633_CR14","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1126\/science.1096502","volume":"304","author":"Y Samuels","year":"2004","unstructured":"Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 2004; 304: 554.","journal-title":"Science"},{"key":"BFcdd201633_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0092-8674(00)80405-5","volume":"91","author":"SR Datta","year":"1997","unstructured":"Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91: 231\u2013241.","journal-title":"Cell"},{"key":"BFcdd201633_CR16","doi-asserted-by":"publisher","first-page":"21085","DOI":"10.1074\/jbc.M400063200","volume":"279","author":"SJ Gardai","year":"2004","unstructured":"Gardai SJ, Hildeman DA, Frankel SK, Whitlock BB, Frasch SC, Borregaard N et al. Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem 2004; 279: 21085\u201321095.","journal-title":"J Biol Chem"},{"key":"BFcdd201633_CR17","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/sj.emboj.7600136","volume":"23","author":"X Qian","year":"2004","unstructured":"Qian X, Karpova T, Sheppard AM, McNally J, Lowy DR . E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J 2004; 23: 1739\u20131748.","journal-title":"EMBO J"},{"key":"BFcdd201633_CR18","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1158\/0008-5472.CAN-13-0180","volume":"73","author":"RCJ Schackmann","year":"2013","unstructured":"Schackmann RCJ, Klarenbeek S, Vlug EJ, Stelloo S, van Amersfoort M, Tenhagen M et al. Loss of p120-catenin induces metastatic progression of breast cancer by inducing anoikis resistance and augmenting growth factor receptor signaling. Cancer Res 2013; 73: 4937\u20134949.","journal-title":"Cancer Res"},{"key":"BFcdd201633_CR19","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1007\/s00018-008-8281-1","volume":"65","author":"F van Roy","year":"2008","unstructured":"van Roy F, Berx G . The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 2008; 65: 3756\u20133788.","journal-title":"Cell Mol Life Sci"},{"key":"BFcdd201633_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1242\/dmm.006395","volume":"4","author":"PWB Derksen","year":"2011","unstructured":"Derksen PWB, Braumuller TM, van der Burg E, Hornsveld M, Mesman E, Wesseling J et al. Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice. Dis Models Mech 2011; 4: 347\u2013358.","journal-title":"Dis Models Mech"},{"key":"BFcdd201633_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0925-4773(02)00090-4","volume":"115","author":"O Boussadia","year":"2002","unstructured":"Boussadia O, Kutsch S, Hierholzer A, Delmas V, Kemler R . E-cadherin is a survival factor for the lactating mouse mammary gland. Mech Dev 2002; 115: 53\u201362.","journal-title":"Mech Dev"},{"key":"BFcdd201633_CR22","doi-asserted-by":"publisher","first-page":"a003129","DOI":"10.1101\/cshperspect.a003129","volume":"1","author":"G Berx","year":"2009","unstructured":"Berx G, van Roy F . Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol 2009; 1: a003129.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"BFcdd201633_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ccr.2006.09.013","volume":"10","author":"PWB Derksen","year":"2006","unstructured":"Derksen PWB, Liu X, Saridin F, van der Gulden H, Zevenhoven J, Evers B et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 2006; 10: 437\u2013449.","journal-title":"Cancer Cell"},{"key":"BFcdd201633_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ccr.2013.06.002","volume":"24","author":"F Vaillant","year":"2013","unstructured":"Vaillant F, Merino D, Lee L, Breslin K, Pal B, Ritchie ME et al. Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancer. Cancer Cell 2013; 24: 120\u2013129.","journal-title":"Cancer Cell"},{"key":"BFcdd201633_CR25","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ccr.2011.12.024","volume":"21","author":"T Muranen","year":"2012","unstructured":"Muranen T, Selfors LM, Worster DT, Iwanicki MP, Song L, Morales FC et al. Inhibition of PI3K\/mTOR leads to adaptive resistance in matrix-attached cancer cells. Cancer Cell 2012; 21: 227\u2013239.","journal-title":"Cancer Cell"},{"key":"BFcdd201633_CR26","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1172\/JCI41695","volume":"121","author":"RCJ Schackmann","year":"2011","unstructured":"Schackmann RCJ, van Amersfoort M, Haarhuis JHI, Vlug EJ, Halim VA, Roodhart JML et al. Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance. J Clin Invest 2011; 121: 3176\u20133188.","journal-title":"J Clin Invest"},{"key":"BFcdd201633_CR27","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.1128\/MCB.25.11.4591-4601.2005","volume":"25","author":"MJ Reginato","year":"2005","unstructured":"Reginato MJ, Mills KR, Becker EB, Lynch DK, Bonni A, Muthuswamy SK et al. Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes. Mol Cell Biol 2005; 25: 4591\u20134601.","journal-title":"Mol Cell Biol"},{"key":"BFcdd201633_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrm3507","volume":"14","author":"A Eijkelenboom","year":"2013","unstructured":"Eijkelenboom A, Burgering BMT . FOXOs: signalling integrators for homeostasis maintenance. Nat Rev Mol Cell Biol 2013; 14: 83\u201397.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcdd201633_CR29","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","volume":"96","author":"A Brunet","year":"1999","unstructured":"Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96: 857\u2013868.","journal-title":"Cell"},{"key":"BFcdd201633_CR30","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646\u2013674.","journal-title":"Cell"},{"key":"BFcdd201633_CR31","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1083\/jcb.200703010","volume":"177","author":"M Curto","year":"2007","unstructured":"Curto M, Cole BK, Lallemand D, Liu CH, McClatchey AI . Contact-dependent inhibition of EGFR signaling by Nf2\/Merlin. J Cell Biol 2007; 177: 893\u2013903.","journal-title":"J Cell Biol"},{"key":"BFcdd201633_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrc3538","volume":"13","author":"P Juin","year":"2013","unstructured":"Juin P, Geneste O, Gautier F, Depil S, Campone M . Decoding and unlocking the BCL-2 dependency of cancer cells. Nat Rev Cancer 2013; 13: 455\u2013465.","journal-title":"Nat Rev Cancer"},{"key":"BFcdd201633_CR33","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/msb.2012.74","volume":"9","author":"A Eijkelenboom","year":"2013","unstructured":"Eijkelenboom A, Mokry M, de Wit E, Smits LM, Polderman PE, van Triest MH et al. Genome-wide analysis of FOXO3 mediated transcription regulation through RNA polymerase II profiling. Mol Syst Biol 2013; 9: 638.","journal-title":"Mol Syst Biol"},{"key":"BFcdd201633_CR34","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.celrep.2013.11.031","volume":"5","author":"A Eijkelenboom","year":"2013","unstructured":"Eijkelenboom A, Mokry M, Smits LM, Nieuwenhuis EE, Burgering BMT . FOXO3 selectively amplifies enhancer activity to establish target gene regulation. Cell Rep 2013; 5: 1664\u20131678.","journal-title":"Cell Rep"},{"key":"BFcdd201633_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/sj.cdd.4401686","volume":"13","author":"Y Zhang","year":"2006","unstructured":"Zhang Y, Adachi M, Kawamura R, Imai K . Bmf is a possible mediator in histone deacetylase inhibitors FK228 and CBHA-induced apoptosis. Cell Death Differ 2006; 13: 129\u2013140.","journal-title":"Cell Death Differ"},{"key":"BFcdd201633_CR36","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/cdd.2012.94","volume":"19","author":"Y Shao","year":"2012","unstructured":"Shao Y, Aplin AE . BH3-only protein silencing contributes to acquired resistance to PLX4720 in human melanoma. Cell Death Differ 2012; 19: 2029\u20132039.","journal-title":"Cell Death Differ"},{"key":"BFcdd201633_CR37","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1158\/0008-5472.CAN-08-3934","volume":"69","author":"MW VanBrocklin","year":"2009","unstructured":"VanBrocklin MW, Verhaegen M, Soengas MS, Holmen SL . Mitogen-activated protein kinase inhibition induces translocation of Bmf to promote apoptosis in melanoma. Cancer Res 2009; 69: 1985\u20131994.","journal-title":"Cancer Res"},{"key":"BFcdd201633_CR38","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1038\/cddis.2011.137","volume":"3","author":"Y Shao","year":"2012","unstructured":"Shao Y, Aplin AE . ERK2 phosphorylation of serine 77 regulates Bmf pro-apoptotic activity. Cell Death Dis 2012; 3: e253.","journal-title":"Cell Death Dis"},{"key":"BFcdd201633_CR39","doi-asserted-by":"publisher","first-page":"e519","DOI":"10.1038\/cddis.2013.9","volume":"4","author":"JE Bolden","year":"2013","unstructured":"Bolden JE, Shi W, Jankowski K, Kan CY, Cluse L, Martin BP et al. HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses. Cell Death Dis 2013; 4: e519.","journal-title":"Cell Death Dis"},{"key":"BFcdd201633_CR40","doi-asserted-by":"publisher","first-page":"e12293","DOI":"10.1371\/journal.pone.0012293","volume":"5","author":"J Chen","year":"2010","unstructured":"Chen J, Gomes AR, Monteiro LJ, Wong SY, Wu LH, Ng T-T et al. Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer. PLoS One 2010; 5: e12293.","journal-title":"PLoS One"},{"key":"BFcdd201633_CR41","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1038\/onc.2009.42","volume":"27 Suppl 1","author":"JD Pi\u00f1on","year":"2008","unstructured":"Pi\u00f1on JD, Labi V, Egle A, Villunger A . Bim and Bmf in tissue homeostasis and malignant disease. Oncogene 2008; 27 Suppl 1: S41\u2013S52.","journal-title":"Oncogene"},{"key":"BFcdd201633_CR42","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1084\/jem.20071658","volume":"205","author":"V Labi","year":"2008","unstructured":"Labi V, Erlacher M, Kiessling S, Manzl C, Frenzel A, O'Reilly L et al. Loss of the BH3-only protein Bmf impairs B cell homeostasis and accelerates gamma irradiation-induced thymic lymphoma development. J Exp Med 2008; 205: 641\u2013655.","journal-title":"J Exp Med"},{"key":"BFcdd201633_CR43","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1158\/2159-8290.CD-14-0353","volume":"4","author":"TN Chonghaile","year":"2014","unstructured":"Chonghaile TN, Roderick JE, Glenfield C, Ryan J, Sallan SE, Silverman LB et al. Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199. Cancer Discov 2014; 4: 1074\u20131087.","journal-title":"Cancer Discov"},{"key":"BFcdd201633_CR44","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/jid.2008.327","volume":"129","author":"LA Miller","year":"2009","unstructured":"Miller LA, Goldstein NB, Johannes WU, Walton CH, Fujita M, Norris DA et al. BH3 mimetic ABT-737 and a proteasome inhibitor synergistically kill melanomas through Noxa-dependent apoptosis. J Invest Dermatol 2009; 129: 964\u2013971.","journal-title":"J Invest Dermatol"},{"key":"BFcdd201633_CR45","doi-asserted-by":"publisher","first-page":"e1593","DOI":"10.1038\/cddis.2014.525","volume":"6","author":"GS Choudhary","year":"2015","unstructured":"Choudhary GS, Al-Harbi S, Mazumder S, Hill BT, Smith MR, Bodo J et al. MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K\/AKT\/mTOR activation in lymphoid malignancies. Cell Death Dis 2015; 6: e1593.","journal-title":"Cell Death Dis"},{"key":"BFcdd201633_CR46","doi-asserted-by":"publisher","first-page":"e24294","DOI":"10.1371\/journal.pone.0024294","volume":"6","author":"SN Reuland","year":"2011","unstructured":"Reuland SN, Goldstein NB, Partyka KA, Cooper DA, Fujita M, Norris DA et al. The combination of BH3-mimetic ABT-737 with the alkylating agent temozolomide induces strong synergistic killing of melanoma cells independent of p53. PLoS One 2011; 6: e24294.","journal-title":"PLoS One"},{"key":"BFcdd201633_CR47","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1073\/pnas.1104778108","volume":"109","author":"SR Oakes","year":"2012","unstructured":"Oakes SR, Vaillant F, Lim E, Lee L, Breslin K, Feleppa F et al. Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737. Proc Natl Acad Sci USA 2012; 109: 2766\u20132771.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd201633_CR48","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/cdd.2010.41","volume":"17","author":"O Kutuk","year":"2010","unstructured":"Kutuk O, Letai A . Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel-induced apoptosis in breast cancer cells. Cell Death Differ 2010; 17: 1624\u20131635.","journal-title":"Cell Death Differ"},{"key":"BFcdd201633_CR49","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/jid.2014.464","volume":"135","author":"N Mukherjee","year":"2015","unstructured":"Mukherjee N, Reuland SN, Lu Y, Luo Y, Lambert K, Fujita M et al. Combining a BCL2 inhibitor with the retinoid derivative fenretinide targets melanoma cells including melanoma initiating cells. J Invest Dermatol 2015; 135: 842\u2013850.","journal-title":"J Invest Dermatol"},{"key":"BFcdd201633_CR50","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1073\/pnas.1019736108","volume":"108","author":"KL Meerbrey","year":"2011","unstructured":"Meerbrey KL, Hu G, Kessler JD, Roarty K, Li MZ, Fang JE et al. The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc Natl Acad Sci USA 2011; 108: 3665\u20133670.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd201633_CR51","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1038\/ncomms4832","volume":"5","author":"ML van de Weijer","year":"2014","unstructured":"van de Weijer ML, Bassik MC, Luteijn RD, Voorburg CM, Lohuis MA, Kremmer E et al. A high-coverage shRNA screen identifies TMEM129 as an E3 ligase involved in ER-associated protein degradation. Nat Commun 2014; 5: 3832.","journal-title":"Nat Commun"},{"key":"BFcdd201633_CR52","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1038\/onc.2011.35","volume":"30","author":"VM Renault","year":"2011","unstructured":"Renault VM, Thekkat PU, Hoang KL, White JL, Brady CA, Kenzelmann Broz D et al. The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor. Oncogene 2011; 30: 3207\u20133221.","journal-title":"Oncogene"}],"container-title":["Cell Death & Differentiation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cdd201633.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd201633","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd201633.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:11:15Z","timestamp":1684415475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cdd201633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,1]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["BFcdd201633"],"URL":"https:\/\/doi.org\/10.1038\/cdd.2016.33","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,1]]},"assertion":[{"value":"10 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}